{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:18:06Z","timestamp":1791933486842,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Daiichi Sankyo, Inc."},{"name":"Eli Lilly & Company"},{"name":"Bristol-Myers Squibb, sanofi-aventis, GlaxoSmithKline, Otsuka, Lilly, Daiichi Sankyo, The Medicines Company, Portola, Accumetrics, Schering-Plough, AstraZeneca"},{"name":"Accumetrics"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jacc.2013.03.037","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T11:44:16Z","timestamp":1366199056000},"page":"505-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel"],"prefix":"10.1016","volume":"62","author":[{"given":"Paul A.","family":"Gurbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Bliden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Lasseter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Nolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Fue","family":"Maa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement K.","family":"Ojeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.03.037_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.109.853085","article-title":"Combination antithrombotic therapies","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.037_bib2","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2012.5930","article-title":"Clopidogrel efficacy and cigarette smoking status","volume":"307","author":"Gurbel","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.03.037_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ahj.2012.12.024","article-title":"Thienopyridine efficacy and\u00a0cigarette smoking status","volume":"165","author":"Bliden","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.03.037_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2008.04.045","article-title":"The association of cigarette smoking with enhanced platelet inhibition by clopidogrel","volume":"52","author":"Bliden","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.037_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcin.2011.09.027","article-title":"Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study","volume":"5","author":"Ueno","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2013.03.037_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2710.2008.00936.x","article-title":"Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel","volume":"33","author":"Yousef","year":"2008","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jacc.2013.03.037_bib7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.111.031195","article-title":"Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients\u00a0treated with antithrombotic agents","volume":"125","author":"Gurbel","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.037_bib8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ahj.2010.12.011","article-title":"The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy","volume":"161","author":"Shuldiner","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.03.037_bib9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.037_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/rcm.2813","article-title":"Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"21","author":"Farid","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jacc.2013.03.037_bib11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jpba.2008.08.020","article-title":"Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS\/MS","volume":"48","author":"Takahashi","year":"2008","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jacc.2013.03.037_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00008571-199406000-00001","article-title":"Simple and reliable CYP1A2 phenotyping by the paraxanthine\/caffeine ratio in plasma and in saliva","volume":"4","author":"Fuhr","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jacc.2013.03.037_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ahj.2011.06.005","article-title":"Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on\u00a0maintenance therapy","volume":"162","author":"Hochholzer","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.03.037_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.037_bib15","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.037_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjcard.2010.04.015","article-title":"Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention","volume":"106","author":"Mangiacapra","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2013.03.037_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/FJC.0b013e3181492209","article-title":"Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel","volume":"50","author":"Payne","year":"2007","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2013.03.037_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.110.034504","article-title":"Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes","volume":"39","author":"Washio","year":"2011","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713014782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713014782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:00:27Z","timestamp":1760014827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713014782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0735109713014782"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.03.037","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718001974.793477848","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718001974.793477474","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718001974.793480328","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2013.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}